Literature DB >> 15471659

Aggressive pharmacological treatment for reversing malignant bowel obstruction.

Sebastiano Mercadante1, Patrizia Ferrera, Patrizia Villari, Antonio Marrazzo.   

Abstract

Early and intensive pharmacological treatment not only may reduce gastrointestinal symptoms but also reverse malignant bowel obstruction. Fifteen consecutive advanced cancer patients with inoperable bowel obstruction received a combination of drugs including metoclopramide, octreotide, dexamethasone and an initial bolus of amidotrizoato. Recovery of intestinal transit was reported within 1-5 days in fourteen patients, who continued this treatment without presenting symptoms of bowel obstruction until death. This case series establishes that the combination of propulsive and antisecretive agents can act synergistically to allow a fast recovery of bowel transit without inducing unpleasant colic. It suggests that the most important mechanism in these circumstances is functional and can be reversible, if an aggressive treatment is initiated early before fecal impaction and edema render bowel obstruction irreversible.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471659     DOI: 10.1016/j.jpainsymman.2004.01.007

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  14 in total

1.  Can malignant bowel obstruction in advanced cancer patients be treated at home?

Authors:  Giampiero Porzio; Federica Aielli; Lucilla Verna; Brigida Galletti; Ghazaleh Shoja E Razavi; Corrado Ficorella
Journal:  Support Care Cancer       Date:  2010-09-25       Impact factor: 3.603

2.  Palliation of gastrointestinal obstruction.

Authors:  Golda Tradounsky
Journal:  Can Fam Physician       Date:  2012-06       Impact factor: 3.275

3.  Outcome prognostic factors in inoperable malignant bowel obstruction.

Authors:  Margarita Romeo; Maria de Los LLanos Gil; José Luís Cuadra Urteaga; Laia Vilà; Sara Ahlal; Alberto Indacochea; Núria Pardo; Joaquim Radua; Albert Font; Albert Tuca
Journal:  Support Care Cancer       Date:  2016-06-10       Impact factor: 3.603

Review 4.  [Pharmacological treatment of malignant bowel obstruction in severely ill and dying patients : a systematic literature review].

Authors:  C Klein; S Stiel; J Bükki; C Ostgathe
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

Review 5.  Palliative surgery versus medical management for bowel obstruction in ovarian cancer.

Authors:  Ali Kucukmetin; Raj Naik; Khadra Galaal; Andrew Bryant; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

6.  Octreotide acetate enables the administration of chemoradiotherapy, including the oral anticancer drug S-1, in gastric cancer patients with malignant gastrointestinal obstruction.

Authors:  Tsunehiro Takahashi; Yoshiro Saikawa; Takahiro Igarashi; Shinichi Tsuwano; Koshi Kumagai; Rieko Nakamura; Takashi Ooyama; Norihito Wada; Hiroya Takeuchi; Hiromasa Takaishi; Yuko Kitagawa
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

7.  Octreotide acetate successfully treated a bowel obstruction caused by peritoneally disseminated gastric cancer, thereby enabling the subsequent use of oral S-1 chemotherapy.

Authors:  Koshi Kumagai; Yoshiro Saikawa; Kazumasa Fukuda; Ryo Ito; Takahiro Igarashi; Shinichi Tsuwano; Rieko Nakamura; Tsunehiro Takahashi; Hiroya Takeuchi; Yuko Kitagawa
Journal:  Int J Clin Oncol       Date:  2009-08-25       Impact factor: 3.402

8.  Management and outcomes of bowel obstruction in patients with stage IV colon cancer: a population-based cohort study.

Authors:  Megan Winner; Stephen J Mooney; Dawn L Hershman; Daniel L Feingold; John D Allendorf; Jason D Wright; Alfred I Neugut
Journal:  Dis Colon Rectum       Date:  2013-07       Impact factor: 4.585

Review 9.  Established and potential therapeutic applications of octreotide in palliative care.

Authors:  Eric E Prommer
Journal:  Support Care Cancer       Date:  2008-02-07       Impact factor: 3.603

10.  Palliative management of malignant bowel obstruction in terminally ill patient.

Authors:  Darshit A Thaker; Bruce C Stafford; Luke S Gaffney
Journal:  Indian J Palliat Care       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.